Performant Healthcare Price to Book Ratio 2011-2024 | PHLT
Historical price to book ratio values for Performant Healthcare (PHLT) over the last 10 years. The current price to book ratio for Performant Healthcare as of February 21, 2025 is 2.40.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Performant Healthcare Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-21 | 2.37 | 2.47 | |
| 2024-09-30 | 3.74 | $0.96 | 3.89 |
| 2024-06-30 | 2.90 | $0.98 | 2.95 |
| 2024-03-31 | 2.94 | $1.01 | 2.91 |
| 2023-12-31 | 3.13 | $1.05 | 2.98 |
| 2023-09-30 | 2.26 | $1.02 | 2.22 |
| 2023-06-30 | 2.70 | $1.02 | 2.64 |
| 2023-03-31 | 3.40 | $1.07 | 3.17 |
| 2022-12-31 | 3.61 | $1.12 | 3.23 |
| 2022-09-30 | 1.85 | $1.13 | 1.64 |
| 2022-06-30 | 2.63 | $1.14 | 2.30 |
| 2022-03-31 | 3.11 | $1.19 | 2.62 |
| 2021-12-31 | 2.41 | $1.19 | 2.03 |
| 2021-09-30 | 3.96 | $1.22 | 3.24 |
| 2021-06-30 | 3.75 | $0.76 | 4.93 |
| 2021-03-31 | 2.15 | $0.70 | 3.09 |
| 2020-12-31 | 0.88 | $0.77 | 1.15 |
| 2020-09-30 | 0.94 | $0.69 | 1.36 |
| 2020-06-30 | 0.65 | $0.64 | 1.01 |
| 2020-03-31 | 0.90 | $0.77 | 1.16 |
| 2019-12-31 | 1.02 | $0.99 | 1.03 |
| 2019-09-30 | 1.10 | $1.06 | 1.04 |
| 2019-06-30 | 1.05 | $1.19 | 0.88 |
| 2019-03-31 | 2.07 | $1.30 | 1.59 |
| 2018-12-31 | 2.25 | $1.46 | 1.54 |
| 2018-09-30 | 2.12 | $1.55 | 1.37 |
| 2018-06-30 | 2.15 | $1.66 | 1.29 |
| 2018-03-31 | 3.00 | $1.73 | 1.73 |
| 2017-12-31 | 1.65 | $1.57 | 1.05 |
| 2017-09-30 | 1.82 | $1.55 | 1.17 |
| 2017-06-30 | 2.09 | $1.63 | 1.28 |
| 2017-03-31 | 2.93 | $1.67 | 1.76 |
| 2016-12-31 | 2.35 | $1.72 | 1.37 |
| 2016-09-30 | 2.95 | $1.94 | 1.52 |
| 2016-06-30 | 1.62 | $1.94 | 0.84 |
| 2016-03-31 | 1.70 | $1.90 | 0.89 |
| 2015-12-31 | 1.79 | $1.90 | 0.94 |
| 2015-09-30 | 2.42 | $1.82 | 1.33 |
| 2015-06-30 | 3.24 | $1.81 | 1.79 |
| 2015-03-31 | 3.40 | $1.78 | 1.91 |
| 2014-12-31 | 6.65 | $1.85 | 3.60 |
| 2014-09-30 | 8.08 | $1.87 | 4.32 |
| 2014-06-30 | 10.10 | $1.83 | 5.51 |
| 2014-03-31 | 9.05 | $1.69 | 5.37 |
| 2013-12-31 | 10.30 | $1.54 | 6.70 |
| 2013-09-30 | 10.90 | $1.35 | 8.07 |
| 2013-06-30 | 11.59 | $1.00 | 11.55 |
| 2013-03-31 | 12.28 | $0.67 | 18.20 |
| 2012-12-31 | 10.10 | $0.53 | 19.05 |
| 2012-09-30 | 10.73 | $0.38 | 28.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.183B | $0.114B |
| Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |